Differences in Medication Use in the Alzheimer's Disease Neuroimaging Initiative: Analysis of Baseline Characteristics

ISSN： 1170-229X

Source： Drugs & Aging, Vol.27, Iss.8, 2010-08, pp. : 677-686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Donepezil: a guide to its use in Alzheimer's disease

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 25, Iss. 9, 2009-09 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Rivastigmine: A Review of its Use in Alzheimer's Disease

By Spencer C.M. Noble S.

Drugs & Aging, Vol. 13, Iss. 5, 1998-11 ,pp. : 391-411

Adis International

Access to resources Recommend Favorite

Galantamine: A Review of its Use in Alzheimer's Disease

By Scott L.J. Goa K.L.

Drugs, Vol. 60, Iss. 5, 2000-11 ,pp. : 1095-1122

Adis International

Access to resources Recommend Favorite

The immunotherapeutic vaccine CAD 106 for use in Alzheimer's disease

Inpharma, Vol. 1, Iss. 1651, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?

By Benzi G. Moretti A.

European Journal of Pharmacology, Vol. 346, Iss. 1, 1998-04 ,pp. : 1-13

Elsevier

Access to resources Recommend Favorite